Call Our HELPLINE: 1-800-4PD-INFO (473-4636)


Caregiver Story: Psychosis

Meet Renee Calvin. She is the primary care partner for her husband Mike, who was diagnosed with Parkinson’s disease in 2011. However, two years ago Mike’s PD progressed in an unexpected way – he began seeing things that were not there and believing things that were not true. Learn more about Renee and Mike’s story.

Research Round Up: New Hope for Better Treating Psychosis

Monday, October 3, 2016
Fernando Cubillos, MD, Director of Research Programs

While reviewing data from the Parkinson's Foundation Parkinson’s Outcomes Project a year ago, I noticed a participant whose quality of life went from pretty good to terrible, then back to pretty good. I wondered, “what happened here?” The answer: psychosis.

What's Hot in PD?: As a New Drug Gains FDA Approval for Parkinson’s Disease Psychosis (Nuplazid), Should We Fear Using it?

Friday, April 1, 2016
Dr. Michael S. Okun

This week the FDA approved the drug Pimavanserin (Nuplazid) for the treatment of Parkinson’s disease psychosis. There has been a critical, unmet need for development of better drugs to address hallucinations and psychosis in the setting of Parkinson's disease. We have learned over many years that typical high potency neuroleptic antipsychotic drugs (e.g.

mail icon

Subscribe to get the latest news on treatments, research and other updates.